Simplifying Global Compliance
FDAnews Drug Daily Bulletin
FDA Agrees to Block Asacol ANDAs, Grants Warner Chilcott’s Petition
Dec. 13, 2011
The FDA has granted a Warner Chilcott citizen petition, agreeing not to approve generic versions of the company’s ulcerative colitis drug Asacol that fail to meet bioequivalence standards using in vitro dissolution and comparative pharmacokinetic (PK) data.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing